bioAffinity Technologies (BIAF) Competitors $5.17 +0.19 (+3.82%) Closing price 04:00 PM EasternExtended Trading$5.16 -0.01 (-0.29%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BIAF vs. RSLS, SJ, LUNA, VIVK, AERT, MOBQ, ESGL, SGRP, EDHL, and DXSTShould you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include ReShape Lifesciences (RSLS), Scienjoy (SJ), Luna Innovations (LUNA), Vivakor (VIVK), Aeries Technology (AERT), Mobiquity Technologies (MOBQ), ESGL (ESGL), SPAR Group (SGRP), Everbright Digital (EDHL), and Decent (DXST). bioAffinity Technologies vs. Its Competitors ReShape Lifesciences Scienjoy Luna Innovations Vivakor Aeries Technology Mobiquity Technologies ESGL SPAR Group Everbright Digital Decent ReShape Lifesciences (NASDAQ:RSLS) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, valuation and media sentiment. Do analysts rate RSLS or BIAF? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ReShape Lifesciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00bioAffinity Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer RSLS or BIAF? In the previous week, bioAffinity Technologies had 6 more articles in the media than ReShape Lifesciences. MarketBeat recorded 6 mentions for bioAffinity Technologies and 0 mentions for ReShape Lifesciences. ReShape Lifesciences' average media sentiment score of 0.00 beat bioAffinity Technologies' score of -0.15 indicating that ReShape Lifesciences is being referred to more favorably in the media. Company Overall Sentiment ReShape Lifesciences Neutral bioAffinity Technologies Neutral Which has more risk & volatility, RSLS or BIAF? ReShape Lifesciences has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of 2.53, suggesting that its stock price is 153% more volatile than the S&P 500. Do insiders and institutionals hold more shares of RSLS or BIAF? 22.1% of ReShape Lifesciences shares are held by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are held by institutional investors. 0.0% of ReShape Lifesciences shares are held by company insiders. Comparatively, 16.9% of bioAffinity Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is RSLS or BIAF more profitable? ReShape Lifesciences has a net margin of -69.71% compared to bioAffinity Technologies' net margin of -152.16%. ReShape Lifesciences' return on equity of -547.65% beat bioAffinity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets ReShape Lifesciences-69.71% -547.65% -79.89% bioAffinity Technologies -152.16%-845.68%-181.92% Which has preferable earnings & valuation, RSLS or BIAF? ReShape Lifesciences has higher earnings, but lower revenue than bioAffinity Technologies. bioAffinity Technologies is trading at a lower price-to-earnings ratio than ReShape Lifesciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioReShape Lifesciences$8.01M1.06-$7.13M-$108.27-0.03bioAffinity Technologies$9.36M0.54-$9.04M-$21.02-0.25 SummaryReShape Lifesciences beats bioAffinity Technologies on 8 of the 14 factors compared between the two stocks. Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIAF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIAF vs. The Competition Export to ExcelMetricbioAffinity TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.07M$3.16B$5.79B$10.48BDividend YieldN/A2.36%5.61%4.57%P/E Ratio-0.2521.17348.8926.86Price / Sales0.54411.81522.55164.18Price / CashN/A44.8326.0131.15Price / Book1.039.8315.536.50Net Income-$9.04M-$52.82M$3.29B$271.42M7 Day Performance-50.82%3.47%200.87%3.69%1 Month Performance-32.05%5.35%184.38%8.07%1 Year Performance-91.63%13.26%325.51%29.65% bioAffinity Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIAFbioAffinity Technologies0.2688 of 5 stars$5.17+3.8%N/A-91.9%$5.07M$9.36M-0.2510Analyst DowngradeStock SplitRSLSReShape LifesciencesN/A$3.16-1.4%N/AN/A$8.49M$8.01M-0.0350Gap DownHigh Trading VolumeSJScienjoy0.706 of 5 stars$0.75+3.0%N/A-13.1%$29.31M$1.33B18.75280Gap DownLUNALuna InnovationsN/A$0.86-9.5%N/A-60.2%$29.21M$116.61M0.00390Gap DownVIVKVivakor0.8133 of 5 stars$0.55-8.8%N/A-69.6%$29.08M$89.81M-0.5120AERTAeries Technology2.1497 of 5 stars$0.61+0.2%N/A-63.2%$28.57M$70.20M-7.591,400News CoverageMOBQMobiquity Technologies0.6119 of 5 stars$1.25flatN/A-40.3%$27.61M$1.24M-1.1210Gap DownESGLESGLN/A$3.56+4.7%N/A+106.4%$27.27M$6.10M0.00N/AGap DownSGRPSPAR Group2.0301 of 5 stars$1.12-0.4%N/A-52.9%$26.53M$163.63M2.193,425EDHLEverbright DigitalN/A$0.97+6.1%N/AN/A$24.26M$2.76M0.007DXSTDecentN/A$1.55+4.7%N/AN/A$24.05M$11.54M0.0016Gap Up Related Companies and Tools Related Companies ReShape Lifesciences Competitors Scienjoy Competitors Luna Innovations Competitors Vivakor Competitors Aeries Technology Competitors Mobiquity Technologies Competitors ESGL Competitors SPAR Group Competitors Everbright Digital Competitors Decent Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIAF) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
